QCM Cayman’s Select Medical SEM Stock Holding History

QCM Cayman’s Portfolio SEM Stock Details SEM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23,406	Closed	-$137K	–	322
2016 Q2	$137K	Buy	+23,406	New	+$155K	0.06%	256

Other funds holding SEM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

NTC

North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

QCM Cayman's SEM Position: Q3 2016 in Review

QCM Cayman sold out of Select Medical (SEM) in Q3 2016, closing a stake of 23,406 shares — an estimated $137K sold.

QCM Cayman first reported a position in SEM in Q2 2016 and held it in 1 quarter. The position peaked at $137K in Q2 2016. 162 funds tracked by Wall St. Rank hold SEM as of Q3 2016.

QCM Cayman reported no remaining Select Medical position as of Q3 2016 after selling out during the quarter.
QCM Cayman sold 23,406 Select Medical shares in Q3 2016, an estimated $137K.
QCM Cayman first reported a position in Select Medical in Q2 2016 and held it in 1 quarter.
QCM Cayman's Select Medical position peaked at $137K in Q2 2016.
162 funds tracked by Wall St. Rank held Select Medical as of Q3 2016.

Based on QCM Cayman's 13F filing for Q3 2016, filed 14 Nov 2016.